Kellerhals Karrard has advised the shareholders of GENE PREDICTIS, a Swiss-based medical diagnostic company and leader in the field of preventive health and precision medicine, in a sale transaction to NIMGenetics Genomica y Medicina (NIM),
Kellerhals Karrard has advised the shareholders of GENE PREDICTIS, a Swiss-based medical diagnostic company and leader in the field of preventive health and precision medicine, in a sale transaction to NIMGenetics Genomica y Medicina (NIM),